Nemus Bioscience (NMUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMUS | BMY | AMGN | GILD | ILMN |
| Company | Nemus Bioscience | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7185 | 43.90 | 313.39 | 65.51 | 127.08 |
| High | 0.7189 | 44.33 | 322.60 | 65.53 | 127.89 |
| Low | 0.6000 | 43.69 | 308.68 | 64.33 | 117.67 |
| Last | 0.6500 | 43.99 | 311.29 | 64.78 | 117.93 |
| Change | -0.0684 | +0.29 | +32.90 | -0.55 | -6.06 |
| % Change | -9.52% | +0.66% | +11.82% | -0.84% | -4.89% |
| Volume | 1,004,500 | 12,104,400 | 9,644,601 | 7,822,700 | 2,987,100 |
| 20-Day Average Volume | 494,515 | 14,464,405 | 2,646,885 | 7,406,455 | 1,469,385 |
| Previous Close | 0.7184 | 43.70 | 278.39 | 65.33 | 123.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5046 | 47.46 | 272.27 | 66.88 | 123.46 |
| 20-Day Raw Stochastic | 72.67% | 7.87% | 81.73% | 8.01% | 11.26% |
| 20-Day Relative Strength | 63.72% | 29.25% | 72.10% | 30.11% | 40.27% |
| Weighted Alpha | +34.72 | -36.67 | +33.76 | -22.64 | -39.11 |
| Today's Opinion | 100% Buy | 100% Sell | 24% Buy | 100% Sell | 88% Sell |
| Previous Opinion | 100% Buy | 88% Sell | 16% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Sell | 100% Sell | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +40.54% since 03/15/19 | -1.92% since 04/26/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 | -3.56% since 04/26/24 |
| Low | 0.4700 on 03/18/19 | 43.33 on 05/02/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 | 117.67 on 05/03/24 |
| High | 0.7440 on 03/21/19 | 45.38 on 04/29/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | +31.31% since 02/22/19 | -15.70% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 | -7.68% since 04/03/24 |
| Low | 0.4000 on 03/11/19 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 115.73 on 04/18/24 |
| High | 0.7440 on 03/21/19 | 52.08 on 04/04/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | +62.54% since 12/21/18 | -9.69% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 | -18.22% since 02/02/24 |
| Low | 0.3000 on 01/31/19 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 115.73 on 04/18/24 |
| High | 0.7440 on 03/21/19 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +120.34% since 09/21/18 | -16.72% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 | +0.86% since 11/03/23 |
| Low | 0.0500 on 10/31/18 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.00 on 11/10/23 |
| High | 0.7440 on 03/21/19 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,040 | 89,172,128 | 166,968,480 | 80,656,088 | 18,780,942 |
| Shares Outstanding, K | 133,908 | 2,027,100 | 536,376 | 1,245,077 | 159,255 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -19,190,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 11,865,000,000 | 8,196,000,000 | 6,686,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -6,220,000 | -11,911,000,000 | 767,000,000 | -4,170,000,000 | -176,000,000 |
| 60-Month Beta | -0.04 | 0.45 | 0.60 | 0.22 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 0.09 on 05/02/24 |
| Latest Earnings Date | 10/05/18 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.62 | 14.94 | 16.21 | 140.90 |